Search

Displaying all 6 results
  1. Indication

    Refractory Inflammatory Myofibroblastic Tumors

    go.drugbank.com/conditions/DBCOND0150134
    Drugs: Crizotinib
  2. Indication

    Relapsed Anaplastic Large Cell Lymphoma

    go.drugbank.com/conditions/DBCOND0146369
    Drugs: Crizotinib
  3. Indication

    Unresectable Inflammatory Myofibroblastic Tumors

    go.drugbank.com/conditions/DBCOND0150133
    Drugs: Crizotinib
  4. Indication

    Refractory Anaplastic Large Cell Lymphoma

    go.drugbank.com/conditions/DBCOND0078800
    Drugs: Crizotinib
  5. Indication

    Recurrent Inflammatory Myofibroblastic Tumors

    go.drugbank.com/conditions/DBCOND0150135
    Drugs: Crizotinib
  6. Indication

    Metastatic Non-Small Cell Lung Cancer

    go.drugbank.com/conditions/DBCOND0043377
    Drugs: Adagrasib · Afatinib · Amivantamab · Atezolizumab · Binimetinib · Brigatinib +32 more